RadiusXR

Executive Summary

RadiusXR is a US-based medical technology company developing a wearable vision diagnostic platform for visual field testing. Its core product is a clinically validated headset integrated with cloud software that enables accurate, portable, and efficient visual field assessments. The platform aims to modernize glaucoma diagnosis and monitoring in ophthalmology and optometry clinics, addressing the limitations of traditional, bulky perimeters that require dedicated space and patient cooperation. By offering a compact, automated solution, RadiusXR seeks to improve workflow, increase testing accessibility, and enhance early detection of vision loss. Founded in 2021 and based in Cambridge, Massachusetts, the company operates in the high-growth drug delivery and ophthalmology markets, with potential to expand into neurology and other fields requiring visual field assessment. Despite being in the early stages with no disclosed funding or valuation, RadiusXR's clinically validated technology positions it for adoption in eye care practices. The platform's portability could enable screening in non-traditional settings, expanding the addressable market. Key challenges include regulatory clearance, reimbursement, and competition from established perimetry devices. However, the shift toward value-based care and point-of-care diagnostics favors innovative, cost-effective solutions. RadiusXR's ability to secure FDA clearance, demonstrate clinical utility in real-world settings, and form partnerships will be critical to its success.

Upcoming Catalysts (preview)

• 2026FDA 510(k) clearance for the vision diagnostic platform70% success
• 2026Publication of clinical validation study in peer-reviewed journal80% success
• 2027Strategic partnership with major ophthalmology clinic network for commercial pilot60% success